Christian Scheffold

6.3k citations
78 papers · 2.5k · 2 hit papers · h-index 26

Impact in

Papers in

Christian Scheffold

76 papers receiving 2.4k citations

Christian Scheffold's Hit Papers

Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial 2022 · 192 citations
1920+2+5Years since publication50100150200250

Peers

Christian Scheffold
Comparison fields: 5 of 75
  • Oncology 885
  • Pulmonary and Respiratory Medicine 971
  • Hematology 339
  • Immunology 567
  • Genetics 262
Replace Thomas A. Puchalski with:
Thomas A. Puchalski United States
Susan C. Guba United States
Marta Salido Spain
Leslie B. Lee United States
Jeff Sosman United States
Ashish M. Ingle United States
Anand Mayakonda United States
Carlos Gomez‐Roca France
Morten Mau‐Sørensen Denmark
Laurie Sherman United States
Christian Scheffold relative to Thomas A. Puchalski United States Thomas A. Puchalski's profile →
Citations per field
00.5×1.5×2×
Thomas A. Puchalski · 1×
Citations per year

Countries citing papers authored by Christian Scheffold

Since Specialization
Citations

This map shows the geographic impact of Christian Scheffold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Scheffold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Scheffold more than expected).

Fields of papers citing papers by Christian Scheffold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Scheffold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Scheffold. The network helps show where Christian Scheffold may publish in the future.

Co-authors

The 25 scholars most cited alongside Christian Scheffold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christian Scheffold Line = papers co-authored together Christian Scheffold links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
Hit paper breakdown →
2018280
2
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
Hit paper breakdown →
2022192
3 2005186
4 2003181
5 2013128
6 2003106
7 202094
8 201187
9 199681
10 201068
11 201762
12 200155
13 202153
14
Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia.
199552
15 201851
16 202250
17 200549
18
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
200240
19 202439
20 200938

About Christian Scheffold

Christian Scheffold is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Molecular Biology and Cancer Research, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (30 papers), Pancreatic and Hepatic Oncology Research (13 papers), Renal and related cancers (11 papers), Immune Cell Function and Interaction (11 papers), Cancer Genomics and Diagnostics (10 papers), T-cell and B-cell Immunology (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Economic and Financial Impacts of Cancer (7 papers). The work is most often cited by research in Oncology (885 citations), Pulmonary and Respiratory Medicine (971 citations), Hematology (339 citations), Immunology (567 citations) and Genetics (262 citations). Christian Scheffold has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Toni K. Choueiri, Robert S. Negrin, Robert J. Motzer, Matthias Edinger, Thomas Leemhuis, Bernard Escudier, Thomas Powles, Geoffrey I. Shapiro, Joachim Kienast and Eric J. Small. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Blood, European Urology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact